ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Increased Breast Density Can Lead to Higher Risk

August 26, 2011

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010